DK2084183T3 - Pegyleret PTH som PTH-receptormodulatorer og anvendelser deraf - Google Patents
Pegyleret PTH som PTH-receptormodulatorer og anvendelser derafInfo
- Publication number
- DK2084183T3 DK2084183T3 DK07843791.0T DK07843791T DK2084183T3 DK 2084183 T3 DK2084183 T3 DK 2084183T3 DK 07843791 T DK07843791 T DK 07843791T DK 2084183 T3 DK2084183 T3 DK 2084183T3
- Authority
- DK
- Denmark
- Prior art keywords
- pth
- applications
- pegylated
- receptor modulators
- pth receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82938306P | 2006-10-13 | 2006-10-13 | |
PCT/US2007/080367 WO2008048784A1 (en) | 2006-10-13 | 2007-10-04 | Pegylated pth as pth receptor modulators and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2084183T3 true DK2084183T3 (da) | 2010-08-16 |
Family
ID=42828673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07843791.0T DK2084183T3 (da) | 2006-10-13 | 2007-10-04 | Pegyleret PTH som PTH-receptormodulatorer og anvendelser deraf |
Country Status (16)
Country | Link |
---|---|
US (1) | US7820179B2 (da) |
EP (1) | EP2084183B1 (da) |
JP (1) | JP5200027B2 (da) |
KR (1) | KR101108354B1 (da) |
CN (1) | CN101522709B (da) |
AT (1) | ATE469173T1 (da) |
AU (1) | AU2007313001B2 (da) |
BR (1) | BRPI0719885B8 (da) |
CA (1) | CA2672907C (da) |
DK (1) | DK2084183T3 (da) |
EA (1) | EA014696B1 (da) |
MX (1) | MX2009003740A (da) |
NO (1) | NO341986B1 (da) |
PL (1) | PL2084183T3 (da) |
SI (1) | SI2084183T1 (da) |
WO (1) | WO2008048784A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201806092TA (en) * | 2016-03-01 | 2018-08-30 | Ascendis Pharma Bone Diseases As | Pth prodrugs |
US11590207B2 (en) * | 2016-09-29 | 2023-02-28 | Ascendis Pharma Bone Diseases A/S | Dosage regimen for a controlled-release PTH compound |
KR102611820B1 (ko) * | 2016-09-29 | 2023-12-07 | 아센디스 파마 본 디지즈 에이/에스 | 낮은 피크 대 트로프 비를 가진 pth 화합물 |
WO2019232280A1 (en) * | 2018-05-30 | 2019-12-05 | Purdue Research Foundation | Targeting anabolic drugs for accelerated fracture repair |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
FR2550204B1 (fr) | 1983-08-05 | 1987-11-13 | Toyo Jozo Kk | Derives peptidiques de (nle8,nle1b, tyr34)-h-pth |
JPS6360940A (ja) | 1986-09-01 | 1988-03-17 | Toyo Jozo Co Ltd | 白内障の予防または治療剤 |
US4771124A (en) | 1987-05-26 | 1988-09-13 | Merck & Co., Inc. | Parathyroid hormone antagonists with simplified synthetic methodology |
EP0293158A3 (en) | 1987-05-26 | 1990-05-09 | Merck & Co. Inc. | Parathyroid hormone antagonists |
JPH0532696A (ja) | 1990-09-28 | 1993-02-09 | Takeda Chem Ind Ltd | 副甲状腺ホルモン誘導体 |
JPH05271279A (ja) | 1991-08-07 | 1993-10-19 | Takeda Chem Ind Ltd | ヒト副甲状腺ホルモンムテインおよびその製造法 |
US5814603A (en) | 1992-06-12 | 1998-09-29 | Affymax Technologies N.V. | Compounds with PTH activity |
US5589452A (en) | 1992-07-14 | 1996-12-31 | Syntex (U.S.A.) Inc. | Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
AU672790B2 (en) | 1992-07-15 | 1996-10-17 | Novartis Ag | Variants of parathyroid hormone and its fragments |
CA2126299C (en) | 1994-06-20 | 2000-12-12 | Gordon E. Willick | Parathyroid hormone analogues for the treatment of osteoporosis |
US6110892A (en) | 1994-06-20 | 2000-08-29 | National Research Council Of Canada | Parathyroid hormone analogues for the treatment of osteoporosis |
US5747456A (en) | 1994-12-19 | 1998-05-05 | Beth Israel Deaconess Medical Center | Continuous low-dose administration of parathyroid hormone or its agonist |
US5717062A (en) | 1995-06-07 | 1998-02-10 | Beth Israel Hospital Association | Cyclic analogs of PTH and PTHrP |
CA2178894A1 (en) | 1995-06-15 | 1996-12-16 | Tsunehiko Fukuda | Parathyroid hormone derivatives and their use |
US5723577A (en) | 1995-07-13 | 1998-03-03 | Biomeasure Inc. | Analogs of parathyroid hormone |
US5955574A (en) | 1995-07-13 | 1999-09-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. | Analogs of parathyroid hormone |
US6544949B1 (en) | 1995-07-13 | 2003-04-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Analogs of parathyroid hormone |
NZ333809A (en) | 1996-08-02 | 2000-07-28 | Ca Nat Research Council | Parathyroid hormone analogues for use as medicaments in treating osteoporosis |
KR100351213B1 (ko) * | 1997-05-14 | 2002-09-05 | 아벤티스 파마슈티칼스 인크. | 펩타이드 부갑상선 호르몬 유사체 및 이를 포함하는 약제학적 조성물 |
JP2001519384A (ja) * | 1997-10-14 | 2001-10-23 | イーライ・リリー・アンド・カンパニー | 骨の構築と維持のための方法 |
IL138214A0 (en) | 1998-03-09 | 2001-10-31 | Zealand Pharmaceuticals As | Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
CN1163504C (zh) | 1998-04-15 | 2004-08-25 | 阿温蒂斯药物公司 | 制备与树脂结合的环状肽的方法 |
WO1999057139A2 (en) | 1998-05-05 | 1999-11-11 | Societe De Conseils De Recherches Et D'applications Scientifiques Sas | Pth2 receptor selective compounds |
US6316410B1 (en) | 1999-09-22 | 2001-11-13 | National Research Council Of Canada | Parathyroid hormone analogues for the treatment of osteoporosis |
US7022815B1 (en) | 1999-09-29 | 2006-04-04 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (PTH) |
WO2001023521A2 (en) | 1999-09-29 | 2001-04-05 | The General Hospital Corporation | Polypeptide derivatives of parathyroid hormone (pth) |
US20050124537A1 (en) | 2000-04-27 | 2005-06-09 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
WO2003009804A2 (en) | 2001-07-23 | 2003-02-06 | The General Hospital Corporation | Conformationally constrained parathyroid hormone (pth) analogs |
WO2003064462A1 (fr) | 2002-02-01 | 2003-08-07 | Chugai Seiyaku Kabushiki Kaisha | Pth a liaison peg ou derive de pth a liaison peg |
US7799757B2 (en) | 2002-06-13 | 2010-09-21 | Michael Chorev | Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents |
TW533925U (en) | 2002-09-26 | 2003-05-21 | Lee Yeong Ind Co Ltd | Improvement of speed-changing transmission mechanism for cutting tools of drill sharpening machine |
AU2002359391A1 (en) | 2002-11-01 | 2004-07-29 | Amgen, Inc. | Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein |
US7432330B2 (en) | 2002-12-31 | 2008-10-07 | Nektar Therapeutics Al, Corporation | Hydrolytically stable maleimide-terminated polymers |
EP1607095A1 (en) * | 2003-03-25 | 2005-12-21 | Sekisui Chemical Co., Ltd. | Antipruritic composition for external use on skin |
US20040220094A1 (en) | 2003-05-01 | 2004-11-04 | Skinner Keith K. | Inverse agonist and agonist peptides that stimulate/inhibit hair growth |
US20050215476A1 (en) | 2004-01-21 | 2005-09-29 | Unigene Laboratories Inc. | Amidated parathyroid hormone fragments and uses thereof |
-
2007
- 2007-10-04 PL PL07843791T patent/PL2084183T3/pl unknown
- 2007-10-04 SI SI200730296T patent/SI2084183T1/sl unknown
- 2007-10-04 CN CN2007800382095A patent/CN101522709B/zh not_active Expired - Fee Related
- 2007-10-04 EA EA200970376A patent/EA014696B1/ru not_active IP Right Cessation
- 2007-10-04 MX MX2009003740A patent/MX2009003740A/es active IP Right Grant
- 2007-10-04 US US12/440,619 patent/US7820179B2/en not_active Expired - Fee Related
- 2007-10-04 KR KR1020097007424A patent/KR101108354B1/ko active IP Right Grant
- 2007-10-04 EP EP07843791A patent/EP2084183B1/en active Active
- 2007-10-04 BR BRPI0719885A patent/BRPI0719885B8/pt not_active IP Right Cessation
- 2007-10-04 WO PCT/US2007/080367 patent/WO2008048784A1/en active Application Filing
- 2007-10-04 AU AU2007313001A patent/AU2007313001B2/en not_active Ceased
- 2007-10-04 DK DK07843791.0T patent/DK2084183T3/da active
- 2007-10-04 CA CA2672907A patent/CA2672907C/en not_active Expired - Fee Related
- 2007-10-04 JP JP2009532504A patent/JP5200027B2/ja not_active Expired - Fee Related
- 2007-10-04 AT AT07843791T patent/ATE469173T1/de active
-
2009
- 2009-04-28 NO NO20091691A patent/NO341986B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BRPI0719885B1 (pt) | 2018-12-11 |
NO341986B1 (no) | 2018-03-12 |
BRPI0719885A2 (pt) | 2014-04-29 |
JP2010506844A (ja) | 2010-03-04 |
PL2084183T3 (pl) | 2010-10-29 |
CA2672907C (en) | 2013-08-06 |
NO20091691L (no) | 2009-05-11 |
CN101522709A (zh) | 2009-09-02 |
ATE469173T1 (de) | 2010-06-15 |
MX2009003740A (es) | 2009-04-22 |
KR101108354B1 (ko) | 2012-01-25 |
CN101522709B (zh) | 2013-03-20 |
EA200970376A1 (ru) | 2009-10-30 |
WO2008048784A1 (en) | 2008-04-24 |
BRPI0719885B8 (pt) | 2021-05-25 |
AU2007313001B2 (en) | 2012-03-22 |
US20090253630A1 (en) | 2009-10-08 |
JP5200027B2 (ja) | 2013-05-15 |
EP2084183B1 (en) | 2010-05-26 |
KR20090067168A (ko) | 2009-06-24 |
EA014696B1 (ru) | 2010-12-30 |
AU2007313001A1 (en) | 2008-04-24 |
EP2084183A1 (en) | 2009-08-05 |
CA2672907A1 (en) | 2008-04-24 |
US7820179B2 (en) | 2010-10-26 |
SI2084183T1 (sl) | 2010-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083011L (no) | Modulatorer av muskarine receptorer | |
UY30304A1 (es) | Moduladores de mglur5 i | |
DK3072507T3 (da) | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi | |
GB2443287B (en) | Methods, compositions and formulations for the treatment of thyroid eye disease | |
DK2021328T3 (da) | Forbindelser og sammensætninger som hedgehog (pindsvin)-signalvejsmodulatorer | |
WO2008115469A3 (en) | Role of hedgehog signaling in atherosclerosis and cardiovascular disease | |
DK2059243T3 (da) | Buprenorphin-vaffel til lægemiddelsubstitutionsterapi | |
UY30308A1 (es) | Moduladores de mglur5 v | |
WO2007077561A3 (en) | Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents | |
IL185277A0 (en) | Pharmaceutical compositions containing roflumilast for the treatment of diabetes | |
ECSP088854A (es) | Moduladores bencimidazolicos de vr1 | |
DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
ZA200701557B (en) | Pharmaceutical compositions comprising diclofenac | |
GB0522311D0 (en) | Pharmaceutical compositions for the treatment of pain | |
DK1871181T3 (da) | Kosttilskud til HIV-patienter | |
UY30307A1 (es) | Moduladores de mglur5 vi | |
NO20071272L (no) | Modulatorer av muskarine reseptorer. | |
UY30306A1 (es) | Moduladores de mglur5 iii | |
MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
DK1810676T3 (da) | Levetiracetam formuleringer og fremgangsmåder til deres fremstilling | |
BRPI1012875B8 (pt) | composições farmacêuticas sólidas e processos para sua produção | |
NO341679B1 (no) | Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren | |
DK2205558T3 (da) | Substituterede n-phenylpyrrolidinylmethylpyrrolidinamider og terapeutisk anvendelse deraf som histamin-h3- receptormodulatorer | |
UY30305A1 (es) | Moduladores de mglur5 iv | |
UY30309A1 (es) | Moduladores de mglur5 ii |